Đang chuẩn bị liên kết để tải về tài liệu:
Efcacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: A propensity score-matched cohort analysis

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Fibrotic hypersensitivity pneumonitis (HP) is a chronic interstitial lung disease caused by allergic responses to repeated exposures to a causative antigen. Therapeutic evidence of the use of corticosteroids to treat fibrotic HP remains lacking, although corticosteroids are recognized as a major treatment option. |

TÀI LIỆU LIÊN QUAN

IMAGENE trial: Multicenter, proof-of-concept, phase II study evaluating the efcacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation

A multicenter randomized trial to assess the efcacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: The CONFIDENT trial protocol

Exploring changes, and factors associated with changes, in behavioural determinants from a low-cost, scalable education intervention about knee osteoarthritis: An observational cohort study

A comparative study of the clinical efcacy of supination-adduction type II ankle fracture surgery based on the medial pilon fracture concept versus the ankle fracture concept

Comparison of the clinical efcacy of a femoral neck system versus cannulated screws in the treatment of femoral neck fracture in young adults

Baseline C-reactive protein predicts efcacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: A retrospective, multicenter study

Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: A meta-analysis on their efcacy and safety

Prevalence of immune-related adverse events and anti-tumor efcacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors

Association between the efcacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: A retrospective study

Evaluating the efcacy and microenvironment changes of HER2+gastric cancer during HLX02 and Endostar treatment using quantitative MRI